PMID- 26609911 OWN - NLM STAT- MEDLINE DCOM- 20161214 LR - 20191210 IS - 1472-8206 (Electronic) IS - 0767-3981 (Linking) VI - 30 IP - 2 DP - 2016 Apr TI - Illicit drugs or medicines taken by parachuting. PG - 185-90 LID - 10.1111/fcp.12172 [doi] AB - Parachuting (also called bombing) is a method of drug delivery where illicit drugs or medicines are ingested after wrapping the substance. There are little data describing parachuting in the literature. To provide a description of this practice, all cases of parachuting reported to the national addictovigilance network up to 31 December 2014 were identified from spontaneous reports and specific surveillance programs. Cases were described according to the type of substance used, patient age and gender, type of complications, context of use and year of the event. Forty-five cases of parachute use were identified and most (n = 43) occurred after 2011. Patients were mostly men (60%), and mean age was 28.9 years. The context of use, known in 19 cases, was mostly recreational. Complications were present in 24 cases, of which eight were serious. The substance was supposed to be 3,4-methylenedioxymethamphetamine (MDMA) in the majority of cases (64.4%); research chemicals were more involved in the most recent years. The physical form was mainly granular (51.6%). The wrappers were a cigarette paper (nine cases) and in one case plastic package; in the other cases, the term of parachute was used without further details. The reason for use was not explained in the majority of cases; two patients indicated using a parachute for faster effect than with a methadone capsule. Clinicians should be aware of this delivery form as the results suggest that it is common and can involve a great variability of drugs. CI - (c) 2015 Societe Francaise de Pharmacologie et de Therapeutique. FAU - Daveluy, Amelie AU - Daveluy A AD - Centre d'Addictovigilance, Service de Pharmacologie Medicale, CHU de Bordeaux, INSERM, U657, Bordeaux, F-33000, France. FAU - Geniaux, Helene AU - Geniaux H AD - Centre d'Addictovigilance, Service de Pharmacologie Medicale, CHU de Bordeaux, INSERM, U657, Bordeaux, F-33000, France. FAU - Eiden, Celine AU - Eiden C AD - Centre d'Addictovigilance, Departement de Pharmacologie Medicale et Toxicologie, CHU de Montpellier, Montpellier, F-34000, France. FAU - Boucher, Alexandra AU - Boucher A AD - Centre d'Addictovigilance, CHU de Lyon, Lyon, F-69000, France. FAU - Chenaf, Chouki AU - Chenaf C AD - Centre d'Addictovigilance, Service de Pharmacologie, CHU de Clermont-Ferrand, Clermont-Ferrand, F-63000, France. FAU - Deheul, Sylvie AU - Deheul S AD - Centre d'Addictovigilance, Departement de Pharmacologie, CHRU de Lille, Lille, F-59037, France. FAU - Spadari, Michel AU - Spadari M AD - Centre d'Addictovigilance PACA Corse, Service de Pharmacologie Medicale et Clinique, AP-HM, Marseille, F-13005, France. FAU - Gerardin, Marie AU - Gerardin M AD - Centre d'Addictovigilance, Departement de Pharmacologie Clinique, CHU de Nantes, Nantes, F-44000, France. FAU - Miremont-Salame, Ghada AU - Miremont-Salame G AD - Centre d'Addictovigilance, Service de Pharmacologie Medicale, CHU de Bordeaux, INSERM, U657, Bordeaux, F-33000, France. FAU - Haramburu, Francoise AU - Haramburu F AD - Centre d'Addictovigilance, Service de Pharmacologie Medicale, CHU de Bordeaux, INSERM, U657, Bordeaux, F-33000, France. CN - French Network of Addictovigilance Centres LA - eng PT - Journal Article DEP - 20151223 PL - England TA - Fundam Clin Pharmacol JT - Fundamental & clinical pharmacology JID - 8710411 RN - 0 (Illicit Drugs) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - UC6VBE7V1Z (Methadone) SB - IM MH - Adolescent MH - Adult MH - Drug Delivery Systems/methods MH - Female MH - Humans MH - Illicit Drugs/*adverse effects/*chemistry MH - Male MH - Methadone/chemistry MH - Middle Aged MH - N-Methyl-3,4-methylenedioxyamphetamine/chemistry MH - Retrospective Studies MH - Young Adult OTO - NOTNLM OT - N-Methyl-3,4-methylenedioxyamphetamine OT - dosage forms OT - drug administration routes OT - parachuting OT - substance-related disorders EDAT- 2015/11/27 06:00 MHDA- 2016/12/15 06:00 CRDT- 2015/11/27 06:00 PHST- 2015/09/18 00:00 [received] PHST- 2015/11/13 00:00 [revised] PHST- 2015/11/20 00:00 [accepted] PHST- 2015/11/27 06:00 [entrez] PHST- 2015/11/27 06:00 [pubmed] PHST- 2016/12/15 06:00 [medline] AID - 10.1111/fcp.12172 [doi] PST - ppublish SO - Fundam Clin Pharmacol. 2016 Apr;30(2):185-90. doi: 10.1111/fcp.12172. Epub 2015 Dec 23.